This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yam, J. W. P. Articles by Ng, I. O.-L. Search for Related Content PubMed PubMed Citation Articles by Yam, J. W. P. Articles by Ng, I. O.-L.

Interaction of Deleted in Liver Cancer 1 with Tensin2 in Caveolae and Implications in Tumor Suppression

¹ Department of Pathology, SH Ho Foundation Research Laboratories and Hong Kong Jockey Club Clinical Research Centre, and ² Department of Biochemistry, Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China

Requests for reprints: Irene Oi-Lin Ng, Department of Pathology, The University of Hong Kong, Room 127B, University Pathology Building, Queen Mary Hospital, Pokfulam, Hong Kong, China. Phone: 852-2855-4197; Fax: 852-2872-5197; E-mail: iolng{at}hkucc.hku.hk.

Deleted in liver cancer 1 (DLC1) is a recently identified tumor suppressor gene frequently underexpressed in hepatocellular carcinoma (HCC). DLC1 encodes a Rho GTPase-activating protein domain that exhibits growth-suppressive activity in HCC cell lines. Our recent finding has revealed that inhibition of Rho-mediated actin stress fiber formation by DLC1 is associated with its growth inhibitory activity. In the present study, we identified tensin2 as the novel binding partner of DLC1. Tensin2 belongs to a new family of focal adhesion proteins that play key roles in cytoskeleton organization and signal transduction. Dysregulation of tensin proteins has previously been implicated in human cancers. Tensin2 is highly expressed in human liver. Introduction of tensin2 into HCC cell lines with low expression of tensin2 caused significant growth inhibition and induction of apoptosis. Tensin2 directly interacted with DLC1 in vitro and in vivo. Both proteins localized to punctate structures in the cytoplasm. Sequence analysis of DLC1 and tensin2 identified caveolin-1 binding motif in both proteins. In vivo immunoprecipitation study confirmed that both proteins indeed interacted with endogenous caveolin-1, which is the major structural component of caveolae. Our findings presented here suggest a new model for the action of DLC1 in hepatocytes, whereby DLC1-tensin2 complex interacts with Rho GTPases in caveolae to effect cytoskeletal reorganization. (Cancer Res 2006; 66(17): 8367-72)

This article has been cited by other articles:

				K. Kawai, Y. Iwamae, M. Yamaga, M. Kiyota, H. Ishii, H. Hirata, Y. Homma, and H. Yagisawa Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells, February 1, 2009; 14(2): 227 - 241. [Abstract] [Full Text] [PDF]

				R.-P. Scholz, J. Regner, A. Theil, P. Erlmann, G. Holeiter, R. Jahne, S. Schmid, A. Hausser, and M. A. Olayioye DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling J. Cell Sci., January 1, 2009; 122(1): 92 - 102. [Abstract] [Full Text] [PDF]

				T. Y. Kim, K. D. Healy, C. J. Der, N. Sciaky, Y.-J. Bang, and R. L. Juliano Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration J. Biol. Chem., November 21, 2008; 283(47): 32762 - 32770. [Abstract] [Full Text] [PDF]

				G. Holeiter, J. Heering, P. Erlmann, S. Schmid, R. Jahne, and M. A. Olayioye Deleted in Liver Cancer 1 Controls Cell Migration through a Dia1-Dependent Signaling Pathway Cancer Res., November 1, 2008; 68(21): 8743 - 8751. [Abstract] [Full Text] [PDF]

				Y.-C. Liao, Y.-P. Shih, and S. H. Lo Mutations in the Focal Adhesion Targeting Region of Deleted in Liver Cancer-1 Attenuate Their Expression and Function Cancer Res., October 1, 2008; 68(19): 7718 - 7722. [Abstract] [Full Text] [PDF]

				X. Qian, G. Li, H. K. Asmussen, L. Asnaghi, W. C. Vass, R. Braverman, K. M. Yamada, N. C. Popescu, A. G. Papageorge, and D. R. Lowy Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities PNAS, May 22, 2007; 104(21): 9012 - 9017. [Abstract] [Full Text] [PDF]